Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Direct effect of incretin hormones on glucose and glycerol metabolism and hemodynamics

Research output: Contribution to journalJournal articleResearchpeer-review

  1. A sandwich ELISA for measurement of the primary glucagon-like peptide-1 metabolite

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Leukemia inhibitory factor increases glucose uptake in mouse skeletal muscle

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Differential time responses in inflammatory and oxidative stress markers after a marathon: An observational study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Characteristics of patients with familial Mediterranean fever in Denmark: a retrospective nationwide register-based cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. 844-P: Effects of Dapagliflozin, Metformin, or Exercise on Plasma Glucagon Concentrations in Individuals with Prediabetes: The PRE-D Trial

    Research output: Contribution to conferenceConference abstract for conferenceResearchpeer-review

View graph of relations

The objective of this study was to assess the insulin-independent effects of incretin hormones on glucose and glycerol metabolism and hemodynamics under euglycemic and hyperglycemic conditions. Young, healthy men (n=10) underwent three trials in a randomized, controlled, crossover study. Each trial consisted of a two-stage (euglycemia and hyperglycemia) pancreatic clamp (using somatostatin to prevent endogenous insulin secretion). Glucose and lipid metabolism was measured via infusion of stable glucose and glycerol isotopic tracers. Hemodynamic variables (femoral, brachial, and common carotid artery blood flow and flow-mediated dilation of the brachial artery) were also measured. The three trials differed as follows: 1) saline [control (CON)], 2) glucagon-like peptide (GLP-1, 0.5 pmol·kg(-1)·min(-1)), and 3) glucose-dependent insulinotropic polypeptide (GIP, 1.5 pmol·kg(-1)·min(-1)). No between-trial differences in glucose infusion rates (GIR) or glucose or glycerol kinetics were seen during euglycemia, whereas hyperglycemia resulted in increased GIR and glucose rate of disappearance during GLP-1 compared with CON and GIP (P<0.01 for all). However, when normalized to insulin levels, no differences between trials were seen for GIR or glucose rate of disappearance. Besides a higher femoral blood flow during hyperglycemia with GIP (vs. CON and GLP-1, P<0.001), no between-trial differences were seen for the hemodynamic variables. In conclusion, GLP-1 and GIP have no direct effect on whole body glucose metabolism or hemodynamics during euglycemia. On the contrary, during hyperglycemia, GIP increases femoral artery blood flow with no effect on glucose metabolism, whereas GLP-1 increases glucose disposal, potentially due to increased insulin levels.

Original languageEnglish
JournalA J P: Endocrinology and Metabolism (Online)
Volume308
Issue number5
Pages (from-to)E426-33
Number of pages8
ISSN1522-1555
DOIs
Publication statusPublished - 1 Mar 2015

    Research areas

  • Adolescent, Adult, Blood Glucose, Blood Pressure, Carotid Artery, Common, Glucose, Glucose Clamp Technique, Glycerol, Heart Rate, Hemodynamics, Humans, Hyperglycemia, Incretins, Male, Pancreas, Regional Blood Flow, Young Adult

ID: 46216071